Agilent
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agilent and other ETFs, options, and stocks.About A
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab.
CEOPadraig Mcdonnell
CEOPadraig Mcdonnell
Employees17,900
Employees17,900
HeadquartersSanta Clara, California
HeadquartersSanta Clara, California
Founded1999
Founded1999
Employees17,900
Employees17,900
A Key Statistics
Market cap38.72B
Market cap38.72B
Price-Earnings ratio32.04
Price-Earnings ratio32.04
Dividend yield0.73%
Dividend yield0.73%
Average volume2.06M
Average volume2.06M
High today$140.57
High today$140.57
Low today$136.00
Low today$136.00
Open price$140.00
Open price$140.00
Volume1.81M
Volume1.81M
52 Week high$153.84
52 Week high$153.84
52 Week low$96.43
52 Week low$96.43
A News
Simply Wall St 1d
Does Agilent’s Security Tech Launch Signal a New Growth Avenue for Agilent Technologies? - simplywall.st...
TipRanks 3d
Agilent price target raised to $165 from $155 at JPMorganJPMorgan analyst Casey Woodring raised the firm’s price target on Agilent (A) to $165 from $155 and keeps an Overweight rating on the shares as part of a Q3 pre...
TipRanks 4d
Agilent initiated with a Buy at Rothschild & Co RedburnRothschild & Co Redburn initiated coverage of Agilent (A) with a Buy rating and $165 price target The firm sees the life science equipment market returning to “...
Analyst ratings
57%
of 21 ratingsBuy
57.1%
Hold
42.9%
Sell
0%
More A News
Nasdaq 6d
Agilent Technologies Reaches Analyst Target PriceIn recent trading, shares of Agilent Technologies, Inc. (Symbol: A) have crossed above the average analyst 12-month target price of $150.83, changing hands for...
People also own
Based on the portfolios of people who own A. This list is generated using Robinhood data, and it’s not a recommendation.